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In brief  
 Current evidence suggests a number of associations between oral diseases and diabetes 
mellitus (diabetes) 
 There is evidence that oral health care/management of oral disease, most notably periodontal 
care, has a short term beneficial influence on diabetes outcomes but there is no evidence that 
this is sustained over the long-term and/or reduces the development of the complications of 
diabetes 
 There is limited evidence to support major changes to medical or dental therapy in the case of 
diagnosis of diabetes; regular periodontal/oral care may benefit patients with periodontitis and 
diabetes 
 At present, diabetes should not be considered a diagnosis that would require a change to 
dental therapy, such as restricting dental implants 
 A diagnosis of diabetes should be considered and excluded in those who have severe 
periodontitis and vice versa 
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Abstract 
Introduction This paper is the third of four rapid reviews undertaken to explore the relationships 
between oral health and general medical conditions in order to support teams within Public Health 
England, health practitioners and policymakers. Aims This review aimed to explore the nature of the 
association between poor oral health and diabetes when found in the same individuals or 
populations, having reviewed the most contemporary evidence in the field. Methods The reviews 
were undertaken by four groups each comprising consultant clinicians from medicine and dentistry, 
trainees, public health and academics. The methodology involved a streamlined rapid review process 
and synthesis of the findings. Results The results identified a number of systematic reviews of low to 
high quality suggesting that diabetes is associated with periodontal disease, tooth loss, and oral 
cancer in particular, and that the management of oral diseases, most notably periodontal care, has a 
short-term beneficial influence on metabolic outcomes related to diabetes; however, there is no 
evidence that this is sustained over the long-term and reduces the prevalence of the long-term 
complications. Conclusion Current evidence, of mixed quality, suggests a number of associations 
between oral diseases and diabetes mellitus (diabetes). Further high quality research is required in 
this field.  
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Background 
In England almost three million people have diabetes and many more are at risk of developing it. The 
estimated national spend by the NHS on diabetes is approximately 10 billion per year (1).  
Diabetes mellitus is a long-term condition characterised by an inability to control the glucose levels in 
the blood due to an absolute or relative lack of the hormone insulin (International Classification of 
Diseases ICD-10 (E08-E13).  
The majority of people with diabetes can be classified as having type 1 or type 2. Type 1 diabetes is an 
autoimmune disease, a group of diseases when the body’s own immune system attacks the body’s own 
host tissues rather than infections. It tends to occur at a younger age and it is essential to treat with 
insulin. Type 2 diabetes is 8-9 times more common than type 1. It occurs as a result of a combination 
of lack of response to insulin (insulin resistance) and lack of insulin production. It tends to occur at a 
later age and in the early stages can be treated with oral medications.  
Elevated glucose levels are associated with a number of complications including blindness, kidney 
failure and minor and major leg amputation which can be prevented by maintaining low glucose levels 
with both lifestyle change and medication. Diabetes foot disease occurs as a result of diabetic peripheral 
neuropathy with high glucose levels associated with a wide range of both chronic and acute 
neuropathies that affect the full anatomic breadth of the peripheral nervous system from the nerve root 
to the skin, mirroring the spectrum of peripheral nerve diseases in general (2). In addition diabetes is 
associated with an increased risk of vascular complications such as myocardial infarction, stroke and 
peripheral vascular disease (3). Obesity is a strong risk factor for the development and progression of 
diabetes. Indeed the increased incidence of overweight and obesity worldwide explains the ever 
increasing number of people affected by type 2 diabetes (4). 
It is preferable to view type 1 and 2 diabetes as separate conditions. Where evidence is in a particular 
type of diabetes this is indicated.  For the purpose of this review we have used the term diabetes alone 
when the population studied is mixed, undifferentiated or not classified in the original article. In general, 
the majority of patients in the studies reviewed would be expected to have type 2 diabetes as it is more 
common.  
The two most common diseases affecting oral health are dental caries and periodontitis. Dental caries 
(caries) is the localised destruction of susceptible dental hard tissues by acidic by-products from 
bacterial fermentation of dietary carbohydrates (5). Periodontitis is a chronic inflammatory disease 
caused by a dysbiosis of the sub-gingival microflora and resulting in the loss of the tissues surrounding 
the teeth (6). Approximately half of all adults in the UK are affected by some level of irreversible 
periodontitis, which increases with age, and almost a third of the same population have obvious dental 
decay (7).  
Both type 1 and 2 diabetes have been associated with many oral diseases in the past. Observational 
studies have suggested diabetes links with periodontal diseases (including peri-implant disease), caries 
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(with its risks of tooth loss), oral mucosal disease (including oral infections), oral cancer, salivary 
dysfunction and oral dysesthesias including taste disturbances. Further clinical studies focused on the 
role of oral diseases and in particular periodontal status or therapy and their effect on hyperglycaemic 
control as well as the role of anti-diabetic medication in oral states. 
However, with all the studies investigating these associations there has been little consensus with 
respect to the overall effect of diabetes mellitus on oral health and vice versa. This has made it difficult 
for both dental and medical clinicians alike to advise patients on these issues with great confidence. By 
pooling together the facts from high quality evidence-based research in one place, this paper should 
provide a source for clinicians to give this advice confidently. 
Review methods  
A rapid review of articles published between 2005 and 2015 investigating the relationship between 
diabetes and oral health was performed. A rapid review is a synthesis of the most current and best 
evidence to inform decision-makers (8). It combines elements of systematic reviews with a streamlined 
approach to summarise available evidence in a timely manner. 
Search syntax was developed based on subject knowledge, MeSH terms and task group agreements 
(Figure 1); followed by duplicate systematic title and abstract searches of three electronic databases: 
Cochrane, PubMed, OVID (Embase, MEDLINE (R), and PsycINFO). Inclusion criteria were systematic 
reviews/meta-analyses involving diabetes and oral health, published in the 10-year period, involving 
human research and the full text being available in English. Exclusion criteria included animal studies 
and only systematic reviews and/or meta-analyses of observational and experimental studies were 
included in the final results. 
Two independent searches were undertaken, screening papers by title and abstract for relevance and 
duplication. Each researcher reviewed their search results and excluded papers that were not 
systematic reviews/meta-analyses, were not related to diabetes and any aspect of oral health, and were 
not available in English despite contacting the authors. After the final selection the searches were 
combined and duplicates removed. Both researchers discussed included and excluded papers and a 
final agreement was made on the papers to be included for the rapid review. A flow diagram of the 
process is shown in Figure 2. 
Figure 2  
The following information was extracted from each paper: author, year, title, journal, population studied, 
oral disease/intervention, definitions used, methods, comparison/intervention and controls, outcomes, 
results, authors’ conclusions, quality and quality justification; all shown in the data extraction table. From 
a total of 2,406 papers initially identified, there were 30 articles identified by the review for inclusion 
(Table 1). Key findings from the rapid review extracted from the information above are shown below, 
with examples of the papers that provide evidence for the results synthesis. Each of the relevant oral 
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health conditions, and relevant therapy, are considered in turn below starting with periodontitis and its 
management. 
Table 1 
Quality assessment was undertaken for each systematic review using the PRISMA and AMSTAR tools 
to ascertain risk of bias. An AMSTAR assessment was carried out on all papers with the methodological 
quality of the review being rated as “High” with a score between eleven and eight, “Moderate” between 
seven and four, and “Low” between four and zero. The quality of all papers was confirmed by group 
discussion. 
The quality of the systematic reviews identified varied. Of the 30 systematic reviews, 12 were deemed 
to be of high quality, 15 of moderate quality and three were of low quality (Table 1). Common AMSTAR 
quality issues were a) lack of a priori design or question, b) no quality appraisal, c) missing tables, and 
d) no duplicate study selection. 
Within the theme identified by this review, reviews related to investigation of i] glycaemic control and 
periodontal therapy and ii] the risk of oral cancer in patients with diabetes were of high quality, whilst 
articles on the association between dental implant therapy (9, 10), osseo-integration (11) and diabetic 
neuropathy (12), with oral diseases or therapy were of low quality. 
 
Results: evidence synthesis  
 
The results are reported in nine sections, each relating to an oral disease or condition investigated. 
Each section contains evidence of any association between the oral disorder and diabetes and also on 
the impact of oral therapy on diabetes and diabetes management on oral health. 
 
I] Periodontitis and diabetes 
There is high quality evidence that diabetes (type 2) is a risk factor for periodontitis (13). There is some 
moderate quality evidence that whilst the extent of periodontitis, i.e. percentage of surfaces/sites 
affected is similar between patients with or without diabetes, measures of severity including greater 
clinical attachment loss and pocket probing depths are greater in patients with diabetes (14). Patients 
with diabetic complications, most specifically diabetic neuropathy, appear to have poorer oral health, 
including periodontitis, than those without neuropathy (12). However, there is scant evidence from two 
reviews of variable quality that diagnosis of periodontitis a) promotes development of type 2 diabetes 
and b) adversely affects glycaemic control and diabetes complications in patients with diabetes (12, 
15). 
 
In summary, whilst there is strong evidence that diabetes is a recognized risk factor for periodontitis, 
more research is needed to ascertain the impact of periodontitis on the development and progression 
of diabetes. 
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II] Periodontal therapy and glycaemic control 
One high quality systematic review provides evidence that in patients with type 2 diabetes, intensive 
periodontal therapy involving scaling and root planning reduced HbA1c (a marker of glycaemic control) 
by 0.29% [3-4 mmol/l] for up to three months; however, after six months there was no evidence that this 
reduction was sustained (16). Modest improvements in glycaemic control, as demonstrated by a 
reduction in Hb1Ac, are supported by seven other moderate quality systematic reviews (15, 17-22); 
whilst one was equivocal (23). In one of the reviews by Wang et al 2014, after three months follow-up, 
periodontal treatment substantially lowered HbA1c compared with no treatment (–0.36%, 95%CI, 
0.52% to 0.19%, P < 0.0001). These findings were accompanied by substantial and statistically 
significant reductions in PPD and CAL between study groups (PPD 0.42 mm, 95%CI: 0.60 to 0.23, 
P<0.00001; CAL 0.34 mm, 95%CI: 0.52 to 0.16, P = 0.0002). Consistent with the 2015 Cochrane 
review, there was no substantial change of HbA1c levels after 6 months (21).  
In summary, there is merit in performing periodontal therapy in patients with type 2 diabetes with regards 
to a short term improvement in metabolic control. Further research is needed to demonstrate that this 
benefit is sustained over longer follow-up and it translates into reduction of diabetes complications. 
 
III] Periodontal therapy and systemic/surrogate markers 
One high quality review suggests that periodontal treatment (SRP) reduced markers of systemic 
inflammation in patients with diabetes: serum levels of TNF- α and CRP (24). Sgolastra et al, 2013 (19) 
reported no significant improvements in lipid fractions (total cholesterol, triglycerides and high and low 
density lipoprotein cholesterol [TC, TG, HDL, or LDL]) in patients with diabetes and chronic periodontitis 
who received scaling and root planning (19). 
Lastly, five different reviews suggest that different types of periodontal treatment; surgical or non-
surgical, with or without the use of adjunctive antibiotics, antiseptics, or oral hygiene instructions do not 
appear to produce different effects on glycaemic control in patients with diabetes (16, 17, 20, 21, 25). 
IV] Tooth loss and diabetes 
Patients with diabetic complications, most specifically diabetic neuropathy, appear to have more tooth 
loss than those without neuropathy (12). This finding is consistent with the view that diabetes and its 
complications are associated with poorer oral health.  
 
V] Caries and diabetes 
Conflicting evidence on the association between diabetes and increased prevalence of caries was 
found. Greater levels of dental plaque were noted in patients with diabetes and this may have 
implications for future risk of caries (26). Furthermore, children with type 1 diabetes are at increased 
risk of periodontal diseases as evidenced by greater dental plaque levels, gingival inflammation and 
bleeding.  
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VI] Dental Implants and diabetes 
There is limited evidence that poor metabolic control is associated with peri-implant disease (27, 28), 
and weak evidence of higher marginal bone loss around dental implants in patients with diabetes with 
unspecified metabolic control (9). There is equivocal evidence that patients with diabetes have higher 
failure rates of dental implants and no evidence that diabetes is a contraindication to dental implant 
placement (10, 11, 29); however, some evidence for delay in implant osteo-integration based on 
glycaemic control was identified (Oates et al., 2013).  
 
VII] Oral surgery and diabetes 
Whilst there is evidence that people with diabetes are more likely to suffer complications of surgery in 
other areas, specific evidence that diabetes is associated with post-operative complications in the oral 
cavity is lacking (30). 
 
VIII] Oral squamous cell carcinoma and diabetes 
A high quality systematic review suggests that type 2 diabetes is associated with an elevated risk of 
oral cancer and precancerous lesions (31). Patients with type 2 diabetes have a higher case mortality 
on diagnosis of oral cancer, independent of tobacco, alcohol and obesity factors with a relative risk of 
1.41(95%CI: 1.16–1.72) when comparing patients with diabetes to people without diabetes, with no 
evident heterogeneity among studies (31). 
 
IX] Saliva and diabetes 
Patients with diabetic complications, most specifically diabetic neuropathy, appear to have greater 
mouth dryness than controls (12). There is limited evidence on the role of diabetes in increasing the 
risk of salivary dysfunction (32). There is some recent, limited and weak evidence that salivary protein 
markers may be used to monitor glycaemic control accurately as a less painful alternative to capillary 
blood glucose measurements (33). 
 
Summary 
The evidence reviewed to form the conclusions for this rapid review demonstrates that there are oral 
manifestations of diabetes, including effects on oral health, periodontitis, oral cancer risk, and that 
diabetes may have an effect on dental implants success. More evidence is required before advising 
clinicians of any contraindications to perform implants in diabetic patients. There is strong evidence of 
type 2 diabetes being a risk factor for periodontal diseases and weak evidence in relation to type 1. 
There is weak evidence in relation to dental caries experience in children. Limited evidence exists of 
periodontitis being a risk factor for diabetes; however, there is a growing body of evidence that 
professional periodontal treatment (ie scaling and root planning as a minimum) results in modest 
improvement in glycaemic control in the short-term but this is not sustained beyond three months. 
Furthermore, the average reduction in glycated haemoglobin observed following periodontal therapy 
(0.3%/3-4 mmol/mol) could translate into long-term clinical benefits but further research is needed. 
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Overall, there is some evidence of a bidirectional relationship between diabetes and oral health and the 
management of conditions, most notably for periodontitis on diabetes. This is a very important area for 
further interdisciplinary patient care and research, particularly as health professionals care for an ageing 
population with multiple co-morbidities. As dental professionals we need to keep abreast of the 
emerging evidence of associations between non-communicable diseases. Whilst there is no evidence 
to support a major change in patient management we should be aware that regular periodontal care 
may benefit patients with periodontitis and diabetes. However, patients with periodontitis need help with 
regular self-care and professional periodontal treatment.  
The rapid nature of the review is a potential limitation especially with the large scope of the topic 
reviewed. However, the methodology used has been proven successful previously in work by Khangura 
et al., (8, 34).This rapid review was limited by the quality of the systematic reviews and meta-analyses 
appraised. These limitations are well summarised in the Cochrane review studies by Simpson et al 
(2010 and updated in 2015) (16, 35), and highlighted in Table 1. Overall the quality of the reviews in 
this field was mixed whilst the research on the topic was generally judged to be of low quality.  
 
It is important to note that the publications do not use standard definitions and classification of 
periodontitis as used by the American guidelines (6); this should be standardised in future to facilitate 
comparability between studies.  
 
There is evidence that management of oral disease, most notably periodontal care, has a short term 
beneficial influence on diabetes but no evidence that this is sustained over the long-term and reduces 
diabetes complications. The vast majority of the articles described define diabetes only by its presence 
or absence and many do not even classify which type of diabetes was present.  There was no 
information regarding the effect of different levels of glucose control on either the absence of presence 
of an association of if the association has a glucose exposure “ dose effect”. Testing the association of 
HBa1c and dental outcomes would therefore be useful future research. Ideally, type 1 and 2 diabetes 
they should be studied separately given the above. More high quality multidisciplinary research is 
needed to investigate relations between the non-communicable diseases and their management as 
shown in Table 2.  
 
Table 2 
In summary, the current evidence suggests a number of associations between oral diseases and 
diabetes. There is limited evidence to support major changes to medical or dental therapy; however, 
regular periodontal/oral care may benefit glycaemic control in patients with periodontitis and diabetes. 
At present, diagnosis of diabetes should not require a change to dental therapy, such as restricting use 
of dental implants. Greater awareness of the impact of diabetes on oral health and vice versa is needed 
among medical and dental health professionals.  
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Tables and figures 
 
Appendix 1  Search terms 
1. ral health and hba1c /ifcc /glycaemic index 
2. oral disease hba1c /ifcc /glycaemic index 
3. mouth and diabetes mellitus    
4. oral manifestations and diabetes mellitus 
5. gingival or gingivitis  and diabetes mellitus                             oral surgery complications and diabetes mellitus 
6. head and neck complications and diabetes mellitus hyposalivation / xerostomia / dry mouth and diabetes mellitus  
7. salivary gland disease and diabetes mellitus      
8. taste disturbance / dysguesia and diabetes mellitus 
9. oral dysaesthesia and diabetes mellitus  
10. halitosis and diabetes mellitus 
11. oral ulcers or oral ulceration and diabetes mellitus recurrent aphthous stomatitis and diabetes mellitus 
12. oral lichen planus and diabetes mellitus  
13. oral cancer and diabetes mellitus  
14. oral squamous cell carcinoma and diabetes mellitus  
15. oral actinomycosis and diabetes mellitus 
16. streptococcus viridans and diabetes mellitus  
17. oral mycobacterial or (oral mycobacterium) and diabetes mellitus 
18. oral tuberculosis and diabetes mellitus   
19. oral viral / virus and diabetes mellitus 
20. oral syphillis and diabetes mellitus   
21. oral hsv or oral herpes simplex or type 1 hsv or type 1 (herpes simplex) and diabetes mellitus 
22. oral infections and diabetes mellitus   
23. oral candida or oral candidosis or oral candidiasis and diabetes mellitus 
24. oral streptococcus and diabetes mellitus   
25. oral hpv or oral human papilloma virus and diabetes mellitus 
26. oral staphylococcal/ staphylococcus aureus and diabetes mellitus   
27. angular cheilitis and diabetes mellitus 
28. mouth disease and diabetes mellitus  
29. oral protozoa and diabetes mellitus 
30. (mouth or oral or dent$).    
31. (periodont$ or gum$ or ging$) 
32. (decay or caries or cavity) 
33. (plaque or biofilm)   
34. (toothbrushing or tooth brushing)   
35. (mouthwash or mouth wash or chlorohexidine or chx)   
36. (tooth loss or edentulous or shortened dental arch)   
37. (loose tooth or loose teeth)   
38. dentures 
39. dry socket or alveolar osteitis or non-healing socket or non-healing socket   
40. xerostomia or dry mouth or hyposalivation 
41. hypersalivation.mp.   
42. bms or burning mouth syndrome or oral dysasthesia or burning sensation  
43. minor oral surgery or tooth extraction or dental extraction 
44. oral or dent$ or mouth or recurrent apthous and ulcer$ or stomatitis or ras   
45. angular chelitis or angular stomatitis 
46. dental implant$  
47. gum inflammation.mp.   
48. oral or dental or socket and healing or non-healing  
49. diabetes or diabetes mellitus or oral diabetes or non insulin dependent diabetes or insulin dependent diabetes or 
niddiabetes mellitus or iddiabetes mellitus or type 1 diabetes or type 2 diabetes 
50. blood glucose or glycemic control or glycaemic control or blood glucose levels or hypoglycaemia or hyperglycaemia 
or glycemic index or glycaemic index  
51. ifcc or hba1 or hba1c or a1c 
52. insulin resista$ 
53. bleeding gums.mp.   
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54. oral thrush or candidia$ or fung$ 
55. tongue or mouth or lips or swallowing or pharynx or oropharynx or throat or teeth 
56. lichen planus or lichenoid   
57. calculus or tartar 
58. chronic inflammation or acute inflammation 
59. resistance to infection.mp. 
60. toothache or tooth ache or tooth pain or dental pain   
61. bad breath or halitosis  
62. oral and white or red 
63. saliv$ gluc$ level$  
64. antifungal$ or antibacterial$   
65. tooth or dental and eruption  
66. systematic review$ or meta ana$ or meta-ana$  
67. saliva
16 
 
 
Figure 2 Flow diagram 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1 Included papers
Records identified through 
database searching 
(n = 3,406) 
Sc
re
e
n
in
g 
In
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d
ed
 
El
ig
ib
ili
ty
 
Id
e
n
ti
fi
ca
ti
o
n
 
Additional records identified 
through other sources 
(n = 649) 
Records after duplicates removed 
(n = 2,406) 
Full-text articles assessed 
for eligibility 
(n = 188 ) 
Full-text articles excluded  
(n =158) 
Studies included in 
qualitative synthesis 
(n =  30 ) 
17 
 
  
Author, year 
and  
paper title 
 
Study 
types in 
the review 
Character-
istic of 
populations 
Oral disease and 
diagnostic criteria or 
oral disease 
intervention and 
description 
Intervention/comparison 
including covariates 
adjusted   
Results  Authors Conclusions AMSTAR rating 
and justification  
Artese et al.  
201525 
 
Periodontal 
therapy and 
systematic 
inflammation in 
type 2 diabetes 
mellitus 
 
9 studies 
-6 RCTs 
-2CCTs 
- Participants 
with type 2 
diabetes 
according to 
the WHO 
criteria 
- Participants 
having 
received PT 
with at least 
3 months of 
follow-up 
- assessment 
of serum 
inflamm-
atory 
biomarkers 
related to 
insulin 
resistance; 
and  
- At least 30 
individuals 
included in 
the type 2 
diabetes 
group 
Periodontitis: any 
periodontitis diagnosis 
definition proposed by  
Authors: Includes 
attachment level and 
probing depths 
Periodontal 
interventions 
oral hygiene 
instructions; full-mouth 
scaling and root planing 
(supra/sub-gingival 
biofilm and calculus 
removal) (SRP); 
surgical procedures (ie, 
periodontal flap surgery) 
and SRP plus local or 
systemic antimicrobial  
 
Effect of periodontal therapy 
(PT) on serum levels of 
inflammatory markers (TNF- 
α and CRP) in people with 
type 2 diabetes mellitus 
Periodontal interventions 
were compared with the 
passive option of no 
periodontal treatment 
 
Covariates: 
none 
1. Periodontal Therapy reduces 
serum levels of inflammatory 
markers (TNF- α and CRP) in 
Type 2 diabetic individuals. The 
meta-analysis showed a 
significant mean difference for 
TNF-Alpha(-1.33 pg/ml, 95% 
CI: -2.10; -0.56,p <0.001) and 
CRP (-1.28 mg/l, 95%CI; -0.48, 
p <0.001) favouring periodontal 
intervention versus control) 
 
2. None of the studies reported 
adverse effects 
1. The results of this meta-analysis 
support the hypothesis that PT reduces 
serum levels of TNF- α and CRP in 
T2DM individuals 
 
2. The decrease of inflammatory 
burden has important implications for 
metabolic control and can, in part, 
explain the mechanisms linking 
periodontitis and increased risk for 
complications in people with T2DM 
High11  
 
Met all Amstar 
criteria 
18 
 
  
Barasch et al. 
200831 
 
Risk factors for 
oral 
postoperative 
infection in 
patients with 
diabetes 
-11 cross 
sectional 
- 5 retro-
spective 
-6 
prospect-
ive 
studies 
 
- All diabetic 
patients 
undergoing 
dental 
surgery  
Post-operative oral 
infections and wound 
healing- no specific 
definitions given 
Oral surgery 
Frequency of post-operative 
infections in patients 
undergoing oral surgery 
procedures 
 
Covariates: 
none specifically; although, 
individual articles within the 
review did note antimicrobial 
use, age, gender, smoking 
status and other medical 
conditions as confounders 
but it is not mentioned if or 
how these were adjusted for 
in the review 
1. Incidence of postoperative 
infections is between 0.5-4%, 
however, poor quality studies  
 
2. Potential risk factors for post-
operative infections include 
age, gender, medical 
conditions, position of the tooth, 
impaction, difficulty of the 
surgery, and experience of the 
surgeon 
 
3. There is strong evidence 
diabetes, perioperative and 
long-term glycaemic control in 
general and in relation to  
surgery 
 
4. There is scant evidence this 
is the same for oral surgical 
procedures 
1. Evidence that diabetes is an 
independent risk factor for 
postoperative infection in general and 
thoracic surgery is strong; however, 
data on infections following dental 
osseous surgery are scant at best 
 
2. Diabetes, evidence suggests that 
micro vascular complications may play 
an important role in elevating risk for 
infection, as could peri-operative and 
longer term glycaemic control 
 
3. Given the increasing prevalence in 
general dental practices of patients 
who are diabetic, many of whom 
require dental osseous surgery, the 
level of uncertainty and the lack of high 
quality evidence suggest that well-
designed studies should be performed 
to accurately quantify the incidence 
and risk of infectious complications in 
dental patients who have diabetes 
 
High9 
 
Looked at a 
relevant topic that 
few others did and 
articles included 
were of 
reasonable quality 
 
Amstar criteria not 
met: 
no full search 
strategy, no 
summary 
measures, no 
method for 
synthesis 
 
19 
 
Borgannakke et 
al. 201513 
 
Is There a 
Relationship 
Between Oral 
Health and 
Diabetic 
Neuropathy 
53 
references 
given. 
Type of 
each not 
mentioned 
Diabetic 
patients with 
neuropathy 
1. Periodontal disease 
in patients with diabetic 
neuropathy 
2. Burning mouth 
syndrome . 
3. Dry mouth  
4. Taste disturbance 
5. Trigeminal pain 
6. Temporomandibular 
joint disorder 
- no criteria or 
definitions provided 
Patients’ simultaneous 
occurrence of diabetic 
neuropathy and oral diseases 
listed 
Covariates: 
none presented 
1. High prevalence of the 
various oral conditions in 
people with diabetic neuropathy 
2. This will negatively influence 
the quality of life 
3. Increased susceptibility to 
gingivitis, periodontitis, tooth 
loss, mouth dryness, and other 
oral health conditions 
4. Periodontal infection is 
shown to adversely affect blood 
glucose levels 
5. Routine, non-surgical 
periodontal therapy is shown to 
be effective in decreasing 
glycated haemoglobin levels by 
about 0.5 percentage point 
glycated haemoglobin, which is 
moderate, but clinically and 
statistically significant 
  
1.There is a lack of awareness by 
people with diabetes of increased oral 
risks 
2. Periodontal infection adversely 
affects blood glucose levels 
3. Periodontal therapy reduces blood 
glucose levels by 0.5% 
4. Inter-professional management of 
diabetes is required 
5. Further exploration of this 
relationship is required 
6.Whether improvement of periodontal 
health will benefit various forms of 
neuropathy still remains to be explored 
7. Propose that further exploration of 
the relationship between diabetic 
neuropathy and oral health may result 
in a potentially important opportunity for 
patient-centred, inter-professional 
collaboration for the benefit of the 
health of the patients 
Low3  
 
Amstar criteria not 
met: 
no duplicate study 
selection, status 
publication not an 
inclusion criteria, 
no comprehensive 
literature, search, 
no status of 
publication, no 
scientific quality 
assessment, no 
synthesis, no 
comment on bias 
 
Borgannake et 
al. 201316 
 
Effect of 
periodontal 
disease on 
diabetes: 
systematic 
review of 
epidemiologic 
observational 
evidence 
17 papers: 
4 cohort 
3 case 
controlled 
not 
presented 
rest 
 
 
 
People with 
diabetes  with 
periodontal 
disease 
undergoing  
periodontal 
therapy 
Periodontal disease and 
therapy. No specific 
definition in selection 
criteria. Definitions listed 
for individual studies 
Periodontal therapy on 
glycaemic control  
 
Covariates: 
none reported by reviewers. 
  
However. reported covariates 
adjusted for in each individual 
study which varied includes 
age, gender, smoking, BMI, 
bone loss and clinical 
1.A small body of evidence 
supports significant, adverse 
effects of periodontal disease 
on glycaemic control, diabetes 
complications, and 
development of type 2 (and 
possibly gestational) diabetes 
2.Compared to periodontally 
healthy individuals, people with 
poor periodontal health and  
- type 2 diabetes, have greater 
risk of developing poorer 
glycaemic control 
1.Scant current evidence suggests that 
periodontal disease adversely affects 
glycaemic control and diabetes 
complications or promotes 
development of type 2 diabetes 
 
2. Large-scale, definitive studies of 
long duration and in multiple different 
population groups in many different 
countries are needed in all the areas 
this review explored 
 
High9 
 
Amstar criteria not 
met: 
no synthesis, no 
conflict of interest 
declared 
20 
 
attachment loss duration, 
baseline HBa1C, etc. 
- type 1 or type 2 diabetes: 
have greater risk for diabetes 
related complications  
- no diabetes: have greater risk 
of developing manifest diabetes 
3. Studies on the effect of 
periodontal disease on 
gestational diabetes are 
inconclusive 
 
Bornstein et al. 
200911 
 
Systemic 
conditions and 
treatments as 
risks for implant 
therapy 
18 studies: 
case 
controlled 
matched 
chart 
survey, 
cohort and 
case 
series 
Patients with 
and without 
diabetes, type 
1 or type 2 
and other risk 
systemic and 
local risk 
factors also  
Dental implants failure: 
no definition of this 
Dental implant failure rates in 
systemic conditions including 
diabetes  
 
Covariates: 
none presented 
1.There was a large 
heterogeneity in papers in a 
review of one database 
 
2. There is unequivocal 
evidence that patients with 
diabetes have higher dental 
implant failure rates. 
 
3. Diabetic patients tend to 
have early failure 
1. it is not possible to distinguish 
between subtypes of systemic 
diseases such as diabetes type 1 and 2 
or primary and secondary osteoporosis 
 
2.The supposition that subjects with 
diabetes tend to have higher failure 
rates is equivocal 
 
Low3 
 
Amstar criteria not 
met: 
no comprehensive 
literature search, 
no tables 
included, no study 
characteristics, no 
synthesis, no 
scientific quality 
assessed 
Carramollino- 
cuellar et al. 
201436 
 
Relationship 
between the oral 
cavity and 
cardiovascular 
diseases and 
metabolic 
syndrome 
40 studies 
- Type of 
studies not 
include. 
Diabetic or 
CHS sufferers 
with 
periodontal 
disease.  
Periodontal disease. No 
definition. 
Bidirectional relationship of 
metabolic syndrome 
(including DM) and 
periodontal disease 
 
Covariates: 
none presented 
1. Evidence suggests that there 
is a moderate association 
between obesity, and 
particularly diabetes mellitus, 
could be related to an increased 
susceptibility to periodontitis.  
 
2. However, it is not clear 
whether periodontal treatment 
could improve the systemic 
conditions of such patients. 
The existing scientific evidence 
suggests that obesity, and particularly 
diabetes mellitus, could be related to 
an increased susceptibility to 
periodontitis. However, it is not clear 
whether periodontal treatment could 
improve the systemic conditions of 
such patients 
 
High8 
 
Amstar criteria not 
met: 
 
No study 
selection, no 
process data 
collection, no 
synthesis  
Chavarry et al. 
200914 
57 papers: 
49 cross 
sectional 
studies, 
Patients with 
periodontal 
disease and 
diabetes (type 
Periodontal disease: 
clinical measures (PPD 
or CAL) radiographic 
Mean differences in PPD and 
CAL  
1. Random effect model 
showed a significant 
association with clinical 
attachment level (mean 
1. There is enough evidence to 
consider type 2 DM as a risk factor for 
destructive periodontal disease.  
High8 
 
21 
 
 
The relationship 
between 
diabetes mellitus 
and destructive 
periodontitis: a 
meta-analysis 
others 
longitudina
l studies 
1 and 2) and 
people without 
diabetes 
evidence of alveolar 
bone loss 
 
Covariates: 
none in selection criteria. 
However variable covariates 
for each paper presented 
including age, gender, 
duration of diabetes, HIV, 
pregnancy, smoking, number 
of teeth 
difference = 1.00 [CI 95% = 
0.15 to 1.84]) and periodontal 
pocket depth (mean difference 
= 0.46 [CI 95% =0.01 to 0.91]) 
between type 2 diabetics and 
non-diabetics 
 
2. Type 2 diabetes mellitus can 
be considered a risk factor for 
periodontitis 
 
2. More studies are needed to assess if 
type 1 DM is a true risk factor for 
periodontal disease 
 
3. In future studies on type 1 DM the 
inclusion of population aged 25 years 
and above is recommended 
Amstar criteria not 
met: 
no study selection 
criteria, no 
excluded table, no 
synthesis no 
conflict of interest 
Chen et al. 
201330 
 
Smoking, 
Radiotherapy, 
Diabetes and 
Osteoporosis as 
Risk Factors for 
Dental Implant 
Failure: A Meta-
Analysis 
58 studies 
5 in 
relation to 
diabetes. 
3 
prospectiv
e and 2 
retrospecti
ve 
observatio
nal studies 
Patients with 
dental 
implants who 
had diabetes  
and other 
systemic 
conditions 
Dental implant failure: 
no definition given 
Comparison of Implant failure 
rates in people with different 
risk factors  
 
Covariates: 
none presented 
For diabetes: no inverse impact 
of diabetes (n = 5; RR = 0.90; 
95% CI, 0.62–1.32) on the risk 
of dental implant failure was 
found 
1. Smoking and radiotherapy were 
associated with an increased risk of 
dental implant failure 
 
2. The relationship between diabetes 
and osteoporosis and the risk of 
implant failure warrant further study 
 
High7 
 
Amstar not met: 
no priori design, 
no characteristics, 
no status in 
selection, no table 
of excluded 
studies, no quality 
assessment 
22 
 
Chrcanovic et al. 
2014 28 
 
Diabetes and 
oral implant 
failure: a 
systematic 
review 
14 studies 
-7 
controlled 
clinical 
trials 
-7 
retrospecti
ve 
analyses 
Type 2 
diabetics with 
dental 
implants and 
healthy 
controls with 
dental 
implants 
Dental implant loss Effects of diabetes mellitus 
on implant failure rates, 
postoperative infections, and 
marginal bone loss 
 
Covariates: 
none set in selection criteria 
and not mentioned any set by 
individual papers 
1. A statistically significant 
difference (p = 0 .001; mean 
difference = 0.20, 95% 
confidence interval =0.08, 0.31) 
between diabetic and non-
diabetic patients concerning 
marginal bone loss, favouring 
non-diabetic patients 
 
2. For postoperative infections. 
The difference did not 
significantly affect implant 
failure rates (p = .65), with a risk 
ratio of 1.07(95% confidence 
interval = 0.80, 1.44) 
1. The results of the present systematic 
review should be interpreted with 
caution because of the presence of 
uncontrolled confounding factors in the 
included studies 
 
2. Within the limits of the existing 
investigations, the difference between 
the insertion of dental implants in non-
diabetic and diabetic patients did not 
statistically affect the implant failure 
rates. However, the studies in the 
review show heterogeneity in eligibility 
criteria for implantation in different 
diabetic populations 
 
3. Studies are lacking that include both 
patient types, with larger sample sizes, 
and that report outcome data 
separately for each group 
High10  
 
Amstar criteria not 
met: 
no exclusion table 
Corbella et al 
2013 26 
 
Effect of 
periodontal  
treatment on 
glycaemic 
control of 
patients with 
diabetes: a 
systematic and 
meta- analysis 
 
15 studies 
were 
included. 
-were 
RCTs or 
interventio
nal studies 
 
People 
undergoing 
non-surgical 
periodontal 
therapy with 
diabetes 
Periodontal disease: no 
definition in selection 
criteria but data 
collected on individual 
papers definitions of 
periodontal disease 
Effect of periodontal 
treatment on Hba1C 
 
Covariates: 
none presented 
1.A reduction of -0.38% (95% 
confidence interval [CI] -0.23 to 
-0.53) after 3–4 months (P < 
0.001) 
2. And 0.31% (95% CI 0.11 to -
0.74) after 6 months (P = 0.15) 
of follow-up was found for 
HbA1c, favouring the treatment 
group 
3. In treated patients, a 
significantly greater decrease in 
FPG was observed in respect to 
control participants 
4.Such difference amounted to -
9.01 mg/dL (95% CI -2.24 to -
15.78) after 3–4 months (P = 
0.009) and -13.62 mg/dL (95% 
1. Periodontal treatment might be 
effective in improving metabolic control 
in terms of reduction of HbA1c and 
FPG concentrations in patients with 
diabetes 
 
2. However, the significance of this 
improvement is questionable and 
should be further investigated 
 
3. Periodontal non-surgical treatment is 
important in periodontal patients 
affected by diabetes because, in 
addition to the negligible side-effects, it 
leads to the reduction of one potential 
factor impairing glycaemic control, 
Moderate6 
 
 
Amstar criteria not 
met: 
no priori design, 
no duplicate study 
selection, no 
exclusion table, 
no synthesis, no 
bias assessed 
23 
 
CI 0.45 to -27.69) after 6 
months (P = 0.06) from 
treatment, respectively 
5.In participants treated with 
adjunctive antimicrobials, a 
non-significant increase of 
HbA1c was observed 3 months 
after treatment, whereas FPG 
decreased by 0.27 mg/dL (95% 
CI 39.56 to -40.11; P = 0.99) 
 
while preserving dental and periodontal 
health 
Darre et al. 2008 
37 
 
Efficacy of 
periodontal 
treatment on 
glycaemic 
control in 
diabetes 
mellitus: meta -
analysis of 
interventional 
studies 
25 studies 
9 RCTs 
16 non- 
controlled 
trials 
Diabetic 
patients with 
periodontal 
disease 
undergoing 
and not 
undergoing 
periodontal 
therapy 
Periodontitis: a common 
chronic gram-negative 
anaerobic infection of 
the periodontium that 
causes destruction of 
periodontal tissues and 
loss of alveolar bone 
(CAL,BOP,PPD,PI,GI) 
Periodontal treatment: 
Root planing scaling, 
OHI and antimicrobial 
therapy 
Effect of periodontal disease 
and treatment on glycaemic 
control 
Covariates adjusted Noted 
from individual papers, 
although all did not account 
for these. Covariates 
adjusted by paper include 
age, BMI, duration of 
diabetes, and number of 
teeth. Also looked at if 
studies reported ethnicity, 
gender, diabetic treatment, 
type of diabetes and its 
treatment and smoking 
The standardised mean 
difference in HbA1c with the 
treatment of periodontal 
disease was 0.46 (95% CI: 
0.11, 0.82). These findings 
suggest that periodontal 
treatment could lead to a 
significant 0.79% (95% CI: 0.19, 
1.40) reduction in HbA1c level 
Periodontal treatment could improve 
glycaemic control. These results need 
to be viewed with caution because of a 
lack of robustness, and deficiencies in 
the design of some of the studies 
included 
High8 
 
 
Amstar criteria not 
met: 
no priori design, 
no exclusion 
table, no 
synthesis 
Engbrettson and 
Koecher 
201318 
 
Evidence that 
periodontal 
treatment 
improves 
diabetes 
outcomes: a 
Systematic 
9 RCT 
studies  
Individuals 
with 
periodontal 
disease and 
diabetes over 
the age of 18 
Periodontal treatment: 
periodontal therapy, 
either surgical or non-
surgical, with or without 
the use of adjunctive 
antibiotics, antiseptics, 
or oral hygiene 
instruction 
The effect of periodontal 
treatment on diabetes 
outcomes 
 
Covariates: 
none presented 
1. Mean treatment effect of 
−0.36% HbA1c (CI −0.54, − 
0.19) compared to no treatment 
after periodontal therapy 
(p<0.0001). 
2. Heterogeneity – low bias (i2) 
3. However, poor sample sizes 
of included studies 
1. The modest reduction in HbA1c 
observed as a result of periodontal 
therapy in subjects with type 2 diabetes 
is consistent with previous systematic 
reviews.  
 
2. Despite this finding, multi-centre 
trials of sufficient sample size are 
lacking 
Moderate7 
 
Amstar criteria not 
met: 
no duplicate study 
selection, no 
comprehensive 
literature search, 
no publication 
status in selection,  
no synthesis 
24 
 
Review and 
Meta-analysis 
 
Morais de 
Freitas 201333 
 
Factors related 
to dry mouth and 
low salivary flow 
rates in diabetic  
elderly: a 
systematic 
literature review  
5 studies 
4 cross 
sectional  
1 
longitudina
l 
Elderly with 
diabetes with 
or without a 
sensation of 
dry mouth 
Salivary dysfunction 
xerostomia 
Factors related to xerostomia 
and/or hypo-salivation in 
elderly patients with diabetes 
 
Covariates: 
age, gender, patient health, 
medications use, disease 
stage, socioeconomic status, 
presence of neuropathy 
Hypo-salivation in elderly 
people with diabetes may occur 
in terms of stimulated response 
in those with poor glycaemic 
control. eg due to drugs/ anxiety 
etc more studies needed to 
confirm this 
1. Cannot draw definitive conclusions 
about the factors that cause xerostomia 
and/or hypo-salivation in elderly 
patients with D.M.  
 
2. More longitudinal studies are needed 
Moderate5  
 
Amstar criteria not 
met: 
no priori design, 
no duplicate 
selection, no 
publication status 
in selection, no 
excluded, no bias 
assesses, no 
conflict of interest 
Gong et al. 
201532 
 
Type 2 diabetes 
mellitus and risk 
of oral cancer 
and 
precancerous 
lesions: A meta-
analysis of 
observational 
studies 
13 studies 
included: 
4 case 
control 
9 cohort 
 
Patients with 
type 2 
diabetes 
mellitus   
Oral cancer and 
precancerous lesions 
Associations between type 2 
diabetes mellitus (type 2 DM) 
and risk of oral cancer and 
precancerous 
Lesions 
 
Covariates: 
covariates adjusted or by 
matching, and the effect 
estimates with 95% Cis were 
only included in the study. 
Though variations in which 
were adjusted for between 
studies. These included age, 
gender, smoking, alcohol, 
duration of chewing, BMI 
physical activity, education, 
diet, family history of cancer, 
health status, marital status 
1. Type 2 DM had a significantly 
elevated incidence of oral 
cancer (SRR = 1.15, 95% CI: 
1.02–1.29; Pheterogeneity = 
0.277, I2 = 15.4%; 10 studies) 
2. Type 2 DM was associated 
with increased oral cancer 
mortality (SRR = 1.41, 95% CI: 
1.16–1.72; 4 studies) 
3. Positive association between 
type 2 DM and risk of oral 
precancerous lesions (SRR = 
1.85, 95%CI: 1.23–2.80; 
Pheterogeneity = 0.038, I2 = 
57.5% 
4. No bias 
The findings of this meta-analysis 
indicate that compared with non-
diabetic individuals, individuals with 
type 2 DM have an elevated risk of oral 
cancer and precancerous lesions 
development 
High11  
 
All Amstar criteria 
met 
Ismail et al. 
201527 
37 studies Children with 
type 1 
diabetes 
Caries  
DMFT 
Oral health status of children 
with type 1 diabetes. 
1. Conflicting evidence 
regarding the caries experience 
of children with type 1 diabetes 
1. There is conflicting evidence 
regarding the caries experience of 
children with type 1 diabetes, but they 
exhibit poorer periodontal health status 
Moderate6  
 
25 
 
 
Oral health of 
children with 
type 1 diabetes 
mellitus: A 
systematic 
review 
7 
longitudina
l 
Rest case 
controlled 
Periodontal health  
Covariates: 
none presented 
2. Exhibit poorer periodontal 
health status  
3. Greater plaque accumulation 
4. Further studies are warranted  
with greater plaque accumulation 
compared to healthy children 
2. Further studies are warranted to 
assess the oral health status of 
children with type 1 diabetes. 
Amstar criteria not 
met: 
No publication 
status in selection, 
no exclusion 
table, no quality 
assessed, no 
synthesis, no bias 
assessed 
Janket et al. 
200538 
 
Does periodontal 
treatment 
improve 
glycaemic 
control in 
diabetic 
patients? A 
Meta-analysis of 
Intervention 
Studies 
10 studies 
all 
interventio
nal 
Type 2 
Diabetics 
patients 
undergoing 
periodontal 
treatment 
Periodontal treatment. 
No definition 
Periodontal treatment effect 
on Hba1C 
 
 
Covariates: 
none presented 
1. A non-significant 0.38% 
reduction in actual value of 
HbA1c, and 0.71% among 5 
studies conducted among 
patients with type 2 diabetes 
2. A non-significant 0.38% 
reduction in actual value of 
HbA1c, and 0.71% among 5 
studies conducted among 
patients with type 2 diabetes 
3. Further studies with a larger 
sample size are needed (246) 
1. Future research  needed 
 
2. Smoking, BMI, and diet, as well as 
baseline characteristics affecting 
glycaemic control - should be adjusted 
fo 
 
3. Participants should be limited to type 
2 diabetic patients on oral 
hypoglycaemic agents or diet regimen 
only, etc 
Moderate7  
 
Amstar criteria not 
met:  
no priori, no status 
of publications in 
selection, no 
synthesis, no 
conflict of interest 
Javed and 
Ramanos 200929 
 
Impact of 
Diabetes Mellitus 
and Glycaemic 
Control on the 
Osseo-
integration of 
Dental Implants: 
A Systematic 
Literature 
Review 
18 studies: 
10 clinical 
8 experi-
mental 
Humans with 
diabetes with 
dental 
implants 
conventional dental 
implants and/or 
immediate loading of 
dental implants 
Can patients with diabetes be 
good candidates for dental 
implant therapy? And how 
does hyperglycaemia and 
glycaemic control influence 
osseo-integration? 
 
 
Covariates: 
none presented 
1. Poorly controlled diabetes 
negatively affects implant 
osseo-integration; however, 
under optimal serum glycaemic 
control, osseo-integration can 
successfully occur in patients 
with diabetes 
2. Use of antiseptic mouth 
rinses and oral-hygiene 
maintenance helps in achieving 
a successful dental implant 
osseo-integration in subjects 
with diabetes  
3. A successful dental implant 
osseo-integration can be 
accomplished in subjects with 
diabetes with good metabolic 
A successful dental implant osseo-
integration can be accomplished in 
subjects with diabetes with good 
metabolic control (serum glycaemic 
level and haemoglobin A1c in normal 
range) in a similar manner as in 
subjects without diabetes 
Moderate5  
 
Amstar criteria not 
met: 
no excluded table, 
no characteristics, 
no quality 
assessment, no 
synthesis, no bias 
assessed 
26 
 
control (serum glycaemic level 
and haemoglobin A1c in normal 
range) in a similar manner as in 
subjects without diabetes 
4. Dental implant therapy in 
diabetics without good 
glycaemic control remains 
contraindicated 
Khader et al. 
200515 
 
Periodontal 
status of 
diabetics 
compared with 
non- diabetics: a 
meta-analysis 
23 studies 
18 
comparativ
e cross 
sectional, 
3prospecti
ve cohort 
and 2 trials 
Diabetics and 
non- diabetics  
with 
periodontitis 
Periodontal status. 
PI,GI, PPD, CAL 
Oral hygiene and periodontal 
disease 
 
Covariates: 
none presented 
1. The severity of oral hygiene 
and POD was worse in 
diabetics.    
2.The extent of POD was 
similar in diabetics and non-
diabetics 
3. Heterogeneity a problem 
Diabetics had a significantly higher 
severity but the same extent of 
periodontal disease than non-diabetics 
Moderate6 
 
Amstar criteria not 
met:  
no comprehensive 
literature search, 
no table of 
excluded studies, 
no quality 
assessed, no 
conflict of interest 
Kudiyirickal  
201439 
 
Diabetes mellitus 
and oral health 
78 studies People with 
diabetes 
Periodontal disease, 
pulp, dry mouth, root 
caries, wound healing 
Oral candidiasis 
No definitions 
Oral health status 
 
Covariates: 
 none presented 
Diabetes can worsen oral 
infections and vice versa. In the 
literature, periodontitis and 
diabetes in the young to middle-
aged adults have been the most 
widely researched area 
Several studies have shown the inter-
link between oral health diabetes, 
thereby highlighting the importance of 
proper management of orofacial 
infections in the reduction of the 
disease-related morbidity from diabetes 
and vice versa 
Moderate4  
 
Amstar criteria not 
met: 
no priori, no 
characteristics, no 
duplicate selection 
no publication 
status in selection, 
no quality 
assessed 
Li et al. 201519 
 
Effect of non-
surgical 
periodontal 
9 RCTs Type 2 
diabetics with 
periodontal 
disease 
Periodontal therapy: 
none defined by 
reviewers. SRP, SRP + 
mouthwash variably in 
individual studies 
Whether non-surgical 
periodontal treatment can 
reduce the Haemoglobin A1c 
(HbA1c) % level in type 2 
diabetic patients 
Pooled analysis (n = 1082) 
showed −0.27 % (95 % CI:-0.46 
% to −0.07 %, p= 0.007) 
absolute difference in HbA1c % 
with treatment while studies 
with sufficient sample size had 
HbA1c % change of −0.014 % 
The moderate reduction in HbA1c after 
the non-surgical therapy in patients 
with type 2 diabetes is consistent with 
previous systematic reviews. However, 
more large scale and high-quality 
Moderate5  
 
Amstar criteria not 
met: 
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treatment on 
glycaemic 
control of 
patients with 
diabetes: a 
meta- analysis of 
RCTs 
 
Covariates: 
none presented 
(95 % CI:-0.18 % to 0.16 %, p= 
0.87) 
RCTs are necessitated to confirm 
these results 
no priori design, 
no duplicate 
selection, no 
public status 
selection, no 
quality assessed, 
no conflict of 
interest 
Masceranhas 
201434 
 
Effect of 
Diabetes Mellitus 
Type 2 on 
Salivary Glucose 
– a systematic 
review and 
meta-analysis of 
observational 
studies 
10 
observatio
nal studies 
Type 2 
Diabetic 
patients 
Saliva glucose content The effectiveness of salivary 
glucose to estimate 
glycaemia and HbA1c. 
 
Covariates: 
none presented 
1. Type 2 DM leads to a 
consistent increase in salivary 
glucose that remains detectable 
in spite of food contamination, 
variations in salivary flow rate or 
presence of local autonomic 
neuropathy.  
2.Our review also reports a 
significant overall relationship 
between salivary glucose 
concentration and associated 
glycaemia/HbA1c values, with 
the correlation strength 
increasing as we move to 
higher glycaemia/HbA1c values 
3. Will allow a less painful and 
invasive method for type 2 DM 
screening or diabetic glucose 
monitoring 
Significant overall relationship between 
salivary glucose concentration 
and associated glycaemia/HbA1c 
values, with the correlation strength 
increasing as we move to higher 
glycaemia/HbA1c values 
Moderate6  
 
Amstar criteria not 
met: 
no duplicate 
selection, no 
status of 
publication in 
selection, no 
excluded table, no 
bias assessment, 
no conflict of 
interest 
Mombelli and 
Cicone 200612 
 
 
Systemic 
diseases 
affecting osseo- 
integration 
therapy 
15: studies 
eight case 
series six 
cross-
sectional, 
longitudina
l or 
retrospecti
ve one 
matched 
control 
retrospecti
ve chart 
survey 
Patients with 
dental implant 
with systemic 
conditions and 
including 
diabetes 
Dental implants. None 
described 
Impact of systemic diseases 
and their treatment on the 
success 
of osseo-integration therapy 
 
Covariates adjusted none 
presented 
1. No unequivocal tendency for 
subjects with diabetes to have 
higher failure rates emerged 
2. A significant increase in the 
relative risk of implant failure 
with diabetes 
The tendency for subjects with 
diabetes to have higher failure rates is 
equivocal 
 
Low3 
 
Amstar criteria not 
met: 
no comprehensive 
literature search, 
no status 
publication in 
selection, no 
excluded table, no 
quality assessed, 
no synthesis, no 
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 bias assesses, no 
conflict of interest 
Oates et al. 
201310 
 
A critical review 
of diabetes, 
glycaemic 
control, and 
dental implant 
therapy 
16 papers Patients with 
diabetes and 
dental 
implants 
Dental implants Implant therapy relative to 
glycaemic control for patients 
with diabetes  
 
Covariates adjusted none 
presented 
1. Reported implant failures 
rates for diabetic patients 
ranged from 0–14.3% 
2. Identification and reporting of 
glycaemic control was 
insufficient or lacking in 13 of 
the 16 studies 
3. Failed to demonstrate a 
significant relationship between 
glycaemic control and implant 
failure, with failure rates ranging 
from 0–2.9% 
Clinical evidence is lacking for the 
association of glycaemic control with 
implant failure while support is 
emerging for implant therapy in 
diabetes patients with appropriate 
accommodations for delays in implant 
integration based on glycaemic control 
 
Low3  
 
Amstar criteria not 
met: 
 
No priori design, 
no excluded table, 
no characteristics, 
no comprehensive 
literature search, 
no quality 
assessed, no 
synthesis, no bias 
assessed 
Mauri-Obradors 
et al. 201524 
 
Effect of 
nonsurgical 
periodontal 
treatment on 
glycosylated 
haemoglobin in 
diabetic patients: 
a systematic 
review - 
 
21: 
13 RCT 
And 8 non 
RCT 
Type 1 
diabetics 
undergoing 
periodontal 
therapy 
Periodontitis: none 
specified by authors. 
Collected definitions 
based on CAL, PPD, 
BOP, PI and number of 
remaining teeth 
Effect of non-surgical 
periodontal therapy in 
reducing hba1c in type 1 
diabetics  
 
Covariates adjusted none 
presented 
1. A significant decrease in 
HbA1c (p <0.05) was found in 
only 14 (66 %) of the studies: 
69 % of the RCTs articles and 
62 % of the non-RCT articles 
2. After 3-4 or 6/12 follow up 
66.7 % of the studies, a 
significant decrease in HbA1c 
after periodontal treatment was 
reported 
3. Only five of the 21 studies 
(23.8 %) were of high 
methodological quality and 
reported significant 
improvements in the metabolic 
control of DM types 1 and 2 
Published literature is insufficient and 
inconclusive to clearly support 
periodontal treatment as a means to 
improve serum HbA1c levels in 
patients with type 1 DM 
Moderate7 
 
Amstar criteria not 
met:  
no publication 
status in selection, 
no quality used 
conclusions, no 
synthesis, no 
assessment of 
bias 
Renvert et al. 
200840 
 
24 papers 
 
Patients with 
peri-implant 
disease 
Dental peri-implant 
mucositis 
perimplantitis 
Peri-implantitis risk factors 
and methods of treating 
these 
 
Potential risk indicators for peri-
implant disease including poor 
oral hygiene, smoking, history 
of periodontitis, diabetes, 
genetic traits, alcohol 
Strong evidence that poor oral hygiene, 
a history of periodontitis and cigarette 
smoking, are risk indicators for peri-
implant disease  
High8  
 
29 
 
 
Non-surgical 
treatment of peri-
implant 
mucositis and 
peri-implantitis: a 
literature review 
- 
Covariates adjusted none 
presented 
consumption and implant 
surface 
 Amstar criteria not 
met: 
no comprehensive 
search strategy, 
no bias assessed, 
no synthesis 
Sgolgostra et al. 
2012 20 
 
Effectiveness of 
Periodontal 
Treatment to 
Improve 
Metabolic 
Control in 
Patients With 
Chronic 
Periodontitis and 
Type 2 Diabetes: 
A Meta-Analysis 
of Randomized 
Clinical Trials 
5 RCTs Patients with 
type 2 
diabetes and 
chronic 
periodontitis 
undergoing 
scaling and 
root planing 
 
Chronic periodontitis: a 
complex disease that 
develops from intra-oral 
biofilms harbouring 
periodontal pathogenic 
micro-organisms. -
Individual studies 
varied- some American 
European consensus 
criteria 
 
Effectiveness of SRP in 
improving glycaemic and 
metabolic control in patients 
with CP and DM2 
 
Covariates adjusted n/a 
SRP was effective in the 
reduction of HbA1c (MD = 0.65; 
95% CI 0.43 to 0.88; P <0.05) 
and FPG (MD =9.04; 95% CI 
2.17 to 15.9; P <0.05), but no 
significant differences were 
found in the reduction of TC, 
TG, HDL, or LDL 
Supports the effectiveness of SRP in 
the improvement of glycaemic control 
in patients with CP and DM2; however, 
future studies are needed to confirm 
these results 
 
High9  
 
Amstar criteria not 
met: 
no priori design no 
scientific quality in 
used in conclusion 
Simpson et al. 
201517 
Cochrane review 
 
Treatment  of 
periodontal  
disease for 
glycaemic 
control in people 
with diabetes 
35 Parallel 
RCT 
studies 
(33 = 
T2DM 
only) 
Patients with 
diabetes, 
periodontitis 
undergoing 
scaling and 
root planning 
above age 16 
 
Periodontal disease is 
the inflammation and 
destruction of the 
underlying supporting 
tissues of the teeth 
 
  
Periodontal therapy (SRP +/- 
adjunctives - surgery, 
antimicrobials, other med) on 
glycaemic control in people 
with diabetes mellitus 
 
Covariates adjusted n/a 
 
1. Reported majority as being at 
high risk of bias (83%), two 
studies (6%) as being at low 
risk of bias, and four studies 
(11%) as unclear 
2. Comparison 1: low quality 
evidence from 14 studies (1,499 
participants) comparing 
periodontal therapy with no 
active intervention/ usual care 
demonstrated that mean HbA1c 
was 0.29% lower (95% 
confidence interval (CI) 0.48% 
Statistically significant improvements 
were shown for all periodontal indices 
(BOP, CAL, GI, PI and PPD) at 3-4 and 
6 months in comparison 1; however, 
this was less clear for individual 
comparisons within the broad category 
of comparison 2 
High11  
 
All Amstar criteria 
met 
30 
 
to 0.10% lower) 3 to 4 months 
post-treatment, and 0.02% 
lower after 6 months (five 
studies, 826 participants; 95% 
CI 0.20% lower to 0.16% 
higher) 
3. Comparison 2: 21 studies 
(920 participants) compared 
different periodontal therapies 
with each other. There was only 
very low quality evidence for the 
multiple head-to-head 
comparisons. specific 
comparison between scaling 
and root planing (SRP) plus 
antimicrobial versus SRP and 
there was no consistent 
evidence that the addition of 
antimicrobials to SRP was of 
any benefit to delivering SRP 
alone (mean HbA1c 0.00% 
lower: 12 studies, 450 
participants; 95% CI 0.22% 
lower to 0.22% higher) at 3-4 
months post-treatment, or after 
6 months (meanHbA1c 
0.04%lower: five studies, 206 
patients; 95%CI 0.41% lower to 
0.32% higher) 
4. The evidence was insufficient 
to conclude whether any of the 
treatments were associated 
with harm.  
5. Studies showed varying 
degrees of success with 
regards to achieving periodontal 
health, with some showing high 
levels of residual inflammation 
following treatment  
31 
 
Sun et al. 201423 
 
Effects of 
periodontal 
treatment on 
glycaemic 
control in type 2 
diabetes mellitus 
patients: a meta-
analysis of RCTs 
8 RCT 
studies 
involving 
515 
participant
s 
Type 2 
diabetics 
having 
periodontal 
therapy 
Periodontal disease: no 
specific definitions 
presented 
Periodontal treatment 
(SRP,OHI, +/-antimicrobials) 
on glycaemic control in t2dm 
patients 
 
 
Covariates adjusted none 
presented 
 
1. 1.03% (95% confidence 
interval: 0.31% to 1.70%, P = 
0.003) from baseline to 3 
months, and 1.18% (95% 
confidence interval: 0.72% to 
1.64%, P <0.001) from baseline 
to 6 months 
2. Indicated that periodontal 
treatment could improve 
glycaemic control in type 2 
diabetic patients with 
periodontal diseases 
Our analysis indicated that periodontal 
treatment could improve glycaemic 
control in type 2 diabetic patients with 
periodontal diseases 
 
Moderate5  
 
Amstar not met:  
 
No priori design, 
no excluded table, 
no publication 
status in selection, 
no quality used in 
conclusion, no 
bias assessed, no 
conflict of interest 
Teew et al. 2010 
21 
 
The effect of 
periodontal 
treatment on 
glycaemic 
control of DM 
pts: a systematic 
review and 
meta-analysis -  
 
5 
controlled 
trial 
studies 
Diabetic 
patients 
undergoing 
periodontal 
treatment 
Periodontitis:  a chronic 
multifactorial  infectious  
disease  of  the  sup- 
porting tissues of the 
teeth  
 
-Individual studies had 
variable definitions of 
periodontitis presented 
 
Periodontal therapy ( SRP 
+OHI +/- adjunctive 
 
Covariates adjusted none 
presented 
 
1. Favouring periodontal 
intervention in type 2 diabetic 
patients. Nevertheless, this 
improvement in %HbA1C  must 
be interpreted with care due to 
limited robustness as evidenced 
by heterogeneity 
among studies 
2. Periodontal treatment leads 
to an improvement of glycaemic 
control in type 2 diabetic 
patients for at least 3 months 
Suggest that periodontal treatment 
leads to an improvement of glycaemic 
control in type 2 diabetic patients for at 
least 3 months 
 
Moderate5  
 
Amstar not met: 
 
No duplicate study 
selection, no 
quality assessed, 
no exclusion 
table, no bias 
assessed no 
quality based  
conclusion 
Wang et al. 2014 
22 
 
Effects of 
Periodontal 
Therapy on 
Metabolic 
Control in 
Patients With 
Type 2 Diabetes 
10 trials of 
1,135 
patients 
Patients with 
periodontitis 
and diabetes 
undergoing 
periodontal 
therapy 
Periodontal disease: a 
multi-factorial infectious 
disease of the soft 
tissues and bone that 
support the teeth. 
Individual studies 
clinical parameters 
presented 
 
periodontal therapies on 
metabolic control in T2DM 
patients with PD 
 
Covariates adjusted none 
presented 
 
1. After the follow-up of 3 
months, treatment substantially 
lowered HbA1c compared with 
no treatment after periodontal 
therapy (–0.36%, 95%CI, 
0.52% to 0.19%, P <0.0001) 
2. Clinically substantial and 
statistically significant reduction 
of PPD and CAL were found 
between subjects with and 
without treatment after 
periodontal therapy (PPD 0.42 
Periodontal treatment leads to the 
modest reduction in HbA1c along with 
the improvement of periodontal status 
in diabetic patients for 3 months, and 
this result is consistent with previous 
systematic reviews, and the effect of 
periodontal treatment on HbA1c cannot 
be observed 6-months after treatment 
 
Moderate7 
 
Amstar not met: 
 
No priori design, 
no duplicate study 
selection, 
No status of 
publication in 
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Mellitus and 
Periodontal 
Disease A Meta-
Analysis   
mm, 95%CI: 0.60 to 0.23, P 
<0.00001; CAL 0.34 mm, 
95%CI: 0.52 to 0.16, P = 
0.0002). 
 3. And there is no significant 
change of the level of HbA1c at 
the 6-month comparing with no 
treatment (–0.30%, 95%CI, 
20.69% to 0.09%, P = 0.13). 
 
selection, no 
exclusion table, 
no quality used in 
conclusion 
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Table 2: Key Questions 
 
 
 
 
Key Questions to be addressed 
 Is diabetes associated with an increased risk of periodontitis and vice versa?  
 Is Type 1 diabetes associated with an increased risk of caries and vice versa? 
 Does regular periodontal care (e.g. 3 monthly scaling and root planing sessions) 
improve glycaemic control and reduce incidence of complications in patients with 
diabetes?  
 What is the impact of common oral diseases (periodontitis and caries) and their 
management on patient-reported outcomes (e.g. quality of life) relevant to diabetes? 
 What is the incidence and risk of infectious complications in patients undergoing dental 
treatment and who have diabetes. 
